Navigation Links
Innovative sobriety project reduces DUI and domestic violence arrests, study finds
Date:11/15/2012

An innovative alcohol monitoring program imposed upon thousands of alcohol-involved offenders in South Dakota helps reduce repeat DUI arrests and domestic violence arrests, according to a new RAND Corporation study.

Examining the first six years of South Dakota's 24/7 Sobriety Project, researchers found that frequent alcohol testing with swift and moderate sanctions for those caught using alcohol reduced county-level repeat DUI arrests by 12 percent and domestic violence arrests by 9 percent. There was mixed evidence about whether the program reduced traffic crashes.

The results, published online by the American Journal of Public Health, are from the first assessment of the program published in a peer-reviewed journal.

"The South Dakota 24/7 Sobriety Project is reducing both repeat DUI and domestic abuse arrests at the county-level," said Beau Kilmer, the study's lead author and a senior policy researcher at RAND, a nonprofit research organization. "The results suggest that frequent alcohol testing with swift, certain and modest sanctions for violations can reduce problem drinking and improve public health outcomes."

Under the South Dakota program, individuals arrested or convicted of an alcohol-involved offense can be required to undergo twice-a-day breathalyzer tests, typically once in the morning and once in the evening, or wear continuous alcohol monitoring bracelets. Individuals who fail or skip required tests are immediately subject to a short jail term, typically a day or two.

The concept was proposed by the South Dakota attorney general in 2004 and by the end of 2010 more than 17,000 of the state's nearly 825,000 residents had participated in the program, including more than 10 percent of the males aged 18 to 40 in some counties.

From 2005 to 2010, program participants were ordered to take approximately 3.7 million breathalyzer tests, with the pass rate exceeding 99 percent (99.3 percent clean, 0.36 percent failed, 0.34 percent no shows), suggesting the program may have helped reduce heavy drinking among those enrolled.

Given that the 24/7 program was adopted in South Dakota's counties at different times, RAND researchers used a "differences-in-differences" approach to assess the impact of the program. The analysis made statistical adjustments for several other factors that could influence the number of alcohol-involved arrests, such as county demographics, snowfall and one large public event that dramatically affects alcohol-related offenses in parts of the state.

Although the program did not appear to reduce the overall traffic crashes, there was suggestive evidence of a modest reduction among male drivers aged 18 to 40.

The 24/7 program is now used throughout South Dakota and similar efforts have been adopted in North Dakota and other jurisdictions.

"It is critical that researchers study whether 24/7 can work outside South Dakota in both rural and urban areas," said study co-author Nancy Nicosia, a RAND senior economist. "It will also be useful to explore how testing programs with swift and certain sanctions can best incorporate positive incentives for compliance as well as treatment services."


'/>"/>

Contact: Warren Robak
robak@rand.org
310-451-6913
RAND Corporation
Source:Eurekalert

Related medicine news :

1. New grants for innovative Alzheimers disease research announced by AHAF
2. NIH awards $7.8 million for innovative HIV vaccine approaches
3. Advances in ataxia research to be featured at USFs Innovative Learning and Simulation Center
4. Saving brains in developing countries: $11.8 million for innovative ideas worldwide
5. Teleconcussion--A new, innovative strategy for assessing young athletes
6. Collegiate inventors honored for innovative science and technology advances
7. How the brains daily clock controls mood: A new project
8. Image share project gives patients and physicians anytime, anywhere access to medical images
9. Optogenetics project takes top NIDA Addiction Science Award
10. Leah Hoskins, F.I.L.M. Project Founder, Headed to Jail?
11. The W3 Project Receives Support from Doulton for Emergency Relief Efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... a new partnership with the Rhode Island Consortium for Autism Research and Treatment ... opportunity for children with autism spectrum disorder (ASD) to see films in an ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... ... February 22, 2017 , ... When ... new healthcare contact center in Georgia, PENETRON Specialty Products (PSP) provided the solution. ... healthcare systems recently invested $51 million to purchase and renovate the 185,000 square-foot ...
(Date:2/22/2017)... Angeles, CA (PRWEB) , ... February 22, 2017 , ... ... detox treatment to the thousands of individuals who have recently fallen victim to America’s ... hospital in Orange County, California, where they are free from the shame, stigma, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... leads to fewer trips the emergency room, fewer hospital admissions, and better blood ... of Managed Care® (AJMC®) finds. The study can be found here . ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017   SeraCare Life ... global in vitro diagnostics manufacturers and clinical laboratories, ... "Catalyzing Implementation of NGS-Based Tests" to be hosted ... 2017 at 11am Eastern Standard Time (US). ... highlight the need for improved performance and global ...
(Date:2/23/2017)... -- ML Capital Group, Inc. (USOTC: MLCG) today announced ... , a Colorado -based cannabis tourism company. ... (USOTC: PURA) to enter Colorado,s $19 billion ... Tours acquisition announced today is intended to accelerate MLCG,s ... ...
(Date:2/23/2017)... DIEGO , Feb. 23, 2017 ... a clinical-stage oncology drug development company, announces that ... and Drug Administration (FDA) authorizing the initiation a ... therapeutic treatment for pancreatic cancer. MVT-1075 ( 177 ... radioimmunotherapy (RIT). MabVax plans to initiate the phase ...
Breaking Medicine Technology: